Neuro Drugs are Still Faltering, Despite Rising Investment

The 28bioGRANT for Neurodegenerative Disease is designed to assist academic researchers in their pursuit to understand the human biological underpinnings of these diseases and translate those insights into potential therapeutic strategies.

Scientists and regulators have long acknowledged the weaknesses in traditional methods used to identify drugs that may harm the central nervous system.